© 2020 MJH Life Sciences and OncLive. All rights reserved.
© 2020 MJH Life Sciences™ and OncLive. All rights reserved.
September 14, 2020
Richard D. Kim, MD, discusses the safety profile of the combination of atezolizumab and bevacizumab in hepatocellular carcinoma.
August 14, 2020
Richard D. Kim, MD, discusses the evolving treatment landscape of advanced hepatocellular carcinoma.
July 03, 2020
Richard D. Kim, MD, discusses the efficacy of and next steps for a phase 1/1b study with regorafenib and nivolumab in patients with mismatch repair proficient advanced refractory colorectal cancer.
December 18, 2019
Richard Kim, MD, discusses the use of immunotherapy in colorectal cancer.